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Optimizing the formation of the 
acquired enamel pellicle in vitro for 
proteomic analysis
Saliva is the major contributor for the protein composition of the acquired 
enamel pellicle (AEP), a bacteria-free organic layer formed by the selective 
adsorption of salivary proteins on the surface of the enamel. However, the 
amount of proteins that can be recovered is even smaller under in vitro 
condition, due to the absence of continuous salivary flow. Objective: This 
study developed an in vitro AEP protocol for proteomics analysis using a 
new formation technique with different collection solutions. Methodology: 
432 bovine enamel specimens were prepared (4x4 mm) and divided into 
four groups (n=108). Unstimulated saliva was provided by nine subjects. 
The new AEP formation technique was based on saliva resupply by a new 
one every 30 min within 120 minutes at 37ºC under agitation. AEP was 
collected using an electrode filter paper soaked in the collection solutions 
according with the group: 1) 3% citric acid (CA); 2) 0.5% sodium dodecyl 
sulfate (SDS); 3) CA followed by SDS (CA+SDS); 4) SDS followed by CA 
(SDS+CA). The pellicles collected were processed for analysis through LC-
ESI-MS/MS technique. Results: A total of 55 proteins were identified. The 
total numbers of proteins identified in each group were 40, 21, 28 and 41 
for the groups CA, SDS, CA+SDS and SDS+CA, respectively. Twenty-three 
typical AEP proteins were identified in all groups, but Mucin was only found 
in CA and CA+SDS, while three types of PRP were not found in the SDS 
group. Moreover, a typical enamel protein, Enamelin, was identified in the 
CA+SDS group only. Conclusion: The new technique of the in vitro AEP 
formation through saliva replacement was essential for a higher number 
of the proteins identified. In addition, considering practicality, quantity and 
quality of identified proteins, citric acid seems to be the best solution to be 
used for collection of AEP proteins.
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Introduction
Saliva is formed mainly by the secretion of salivary 
glands. This fluid is essential for the homeostasis of 
the oral cavity, since it cleans, lubricates and protects 
the oral tissues, as well as acting as a buffering 
agent and source of calcium and phosphate ions for 
remineralization of the teeth.1 Moreover, saliva is the 
major contributor for the protein composition of the 
acquired enamel pellicle (AEP), a bacteria-free organic 
layer formed by the selective adsorption of salivary 
proteins on the surface of the enamel,2 but containing 
also carbohydrates, neutral lipids, phospholipids 
and glycolipids.3-5 These organic components grant 
important functions to the AEP that acts as a diffusion 
barrier, reducing the direct contact of the acids with 
the tooth surface, slowing down tooth dissolution.1,6,7
The ability of the AEP to protect the enamel surface 
against acids is due mainly to its protein composition, 
especially by the proteins present in the basal layer. 
These remain in the AEP after exposure to acids8 and 
are currently objects of great interest, since they might 
protect against dental caries and erosion. In the last 
few years, proteomic approaches have been used to 
identify these proteins9-12 so that they can be added 
to dental products which, when applied, could modify 
the composition of the AEP, increasing its protective 
potential against acids.13
One of the main difficulties faced in the studies 
involving proteomic analysis of the AEP is the small 
amount of proteins that can be obtained, which can 
impair analysis, both in in vitro, in situ and in vivo. 
The amount of proteins that can be recovered is even 
smaller under in vitro condition, due to the absence 
of continuous salivary flow. Moreover, in the in vivo 
studies available so far, AEP samples collected from 
8-10 volunteers are pooled in order to obtain enough 
proteins to be analyzed by mass spectrometry,10-12,14-18 
which does not allow proper assessment of the 
biological variation of the samples. In these in vivo 
studies, the collection of the AEP samples is done with 
filter paper soaked in 3% citric acid. 
Recently, the proteome of the acquired pellicle 
formed in situ on ceramic specimens and collected by 
incubation in Tris-HCl buffer containing Triton X-100 
followed by ultrasonication in RIPA buffer was analyzed 
from individual volunteers, with high inter-individual 
and inter-day consistency.19 However, the protocol of 
collection of the AEP employed by Delius 201719 is not 
viable to be employed in vivo, since Triton X-100 is 
toxic and sonication is not possible. In addition, 0.5% 
dodecyl sodium sulphate (SDS) has been employed for 
the collection of AEP samples for analysis of individual 
proteins by immunoblotting,20 but SDS was not tested 
for collection of AEP samples for proteomic analyses 
yet. 
Thus, the aim of this study was to develop an 
in vitro AEP formation protocol comparing different 
collection solutions for shotgun proteomic analysis. 
The solutions tested (3% citric acid and 0.5% 
SDS, alone or in combination) were chosen based 
on their potential to be employed under in vivo 
conditions, which would allow individual analysis and 
better assessment of biological variation among the 
volunteers in future studies. 
Methodology
Ethical aspects and subjects
This study was approved by the local Ethics 
Committees (Human and Animal, protocols 
86772718.0.0000.5417 and 007/2018, respectively) 
of Bauru School of Dentistry, University of São Paulo, 
SP, Brazil). 
Nine young adult subjects of both genders took 
part in the study, after signing an informed consent 
document. The exclusion criteria for the volunteers 
were: presence of caries lesions, use of medication 
that could change the salivary flow, gingivitis, smoking 
habit, periodontitis, low salivary flow (unstimulated 
and stimulated flows should be greater than 0.1 and 
1.0 mL/minute, respectively). 
The volunteers received a kit containing a 
toothbrush, toothpaste and floss for oral hygiene 
standardization. In the morning (to avoid circadian 
effects),21 after oral hygiene (2 hours), unstimulated 
saliva was collected from each volunteer in tubes, kept 
in ice. Saliva samples were immediately centrifuged 
(4.500 xg at 4°C, 15 min). The supernatants were 
collected, pooled and added to a 1:100 protease 
inhibitor (phenylmethane sulfonyl fluoride - PMSF, 
N-Ethyhlmaleimide - NEM and Phenantroline).9 Saliva 
supernatants were stored at -80ºC, until use.
Preparation of bovine specimens
Bovine incisors underwent a process of screening 
and cleaning (removal of soft tissue) before 
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preparation. Each tooth was glued on an acrylic plate 
with thermoactive dental plaster (Kerr Corporation, 
Orange, CA, EUA) for the separation of the root 
and coronary portions. The crowns were cut using a 
precision cutting machine (ISOMET Low Speed Saw 
Buehler Ltd., Lake Bluff, IL, EUA), with two diamond 
discs (double-sided XL 12205 ‘high concentration’, 102 
× 12.7 × 0.3 mm3; Extec Diamont Wafering Blade, 
Enfield, CT, USA) separated by a 4-mm thick spacer, 
in order to obtain 4 × 4 × 2 mm enamel specimens. 
Study groups
A total of 432 standardized bovine enamel 
specimens were obtained and divided into four groups 
(n=108/group), according to the solution used to 
collect the AEP, as follows: 1) 3% citric acid (CA)16; 
2) 0.5% sodium lauryl sulfate (SDS)20; 3) CA followed 
by SDS (CA+SDS); 4) SDS followed by CA (SDS+CA). 
Formation of AEP in vitro
For the formation of the AEP, the specimens were 
placed in 96-well microplates in which 250 µL of saliva 
were added. The AEP was then allowed to form for 120 
min. For the constant control of the temperature and 
agitation, a ThermoMixer® (Eppendorf ThermoMixer® 
C, Hamburg, Germany) was used at 37°C, under 
agitation. The mainly particularity in this study was the 
new methodology adopted regarding the resupply of 
saliva. For this, during the AEP formation (120 min), 
saliva was exchanged three times (every 30 min). 
This way, the previous saliva was removed and a new 
sample was immediately added (250 µL).
Collection of the AEP
After the formation of AEP, the specimens were 
immediately withdrawn from saliva and washed with 
a small spray of deionized water for three seconds and 
air dried. The AEP was collected using an electrode 
filter paper 5 × 10 mm (Electrode Wick, Bio-Rad, 
Hercules, CA, USA) soaked in the collection solutions 
according with the respective group. The excess of the 
acid was removed with absorbent paper. For CA+SDS 
and SDS+CA groups, one filter paper was used for the 
first solution and a new filter paper was used for the 
second one. One filter paper was used for 6 specimens 
only and then resupplied by a new one. 
For AEP collection, each paper soaked with their 
respective solution was rubbed (no pressure) on the 
enamel surface, with the aid of tweezers.16 The filter 
papers used to collect AEP from the specimens of the 
same group were placed in 2 mL tubes and stored at 
-80°C. The experiment was repeated for additional 2 
consecutive days. 
Shotgun proteomics analysis by NanoLC-ESI-
MS/MS
The methods were exactly as described elsewhere.17 
The papers with the samples were cut into small pieces 
with the aid of sterile scissors and tweezers. The filter 
papers containing the AEP collected from 3 different 
days (triplicate collection) for each of the groups were 
pooled to obtain enough amount of AEP proteins to be 
submitted to the proteomic analysis. 
The peptides identification was performed on a 
nanoACQUITY UPLC-Xevo QTof MS system (Waters, 
Manchester, UK). In addition, ProteinLynx Global 
Server (PLGS) version 3.0 was used to process and 
search the continuum LC-MSE data. Samples from 
each group were analyzed in triplicate (technical 
triplicates). Proteins were searched for on the Homo 
sapiens proteome database (reviewed only, UniProtKB/
Swiss-Prot) downloaded on April 2017 from UniProtKB 
(http://www.uniprot.org/).17 
Finally, the identified proteins were classified 
and assigned by biological function,18, 22 origin and 
molecular interaction (http://www.uniprot.org/) (Table 
S1).
Results
The total amount of AEP proteins recovered was 
very similar for all the groups, ranging between 26 and 
33 µg. A total of 55 proteins were identified (Figure 1), 
among which are 20 proteins typically found in the AEP, 
such as two isoforms of Alpha-amylase, two isoforms 
of Basic salivary proline-rich protein, three isoforms 
of Cystatin, five isoforms of Hemoglobin, Lysozyme, 
Mucin-7, Pancreatic alpha-amylase, Proline-rich 
protein 4, Protein S100-A9, Salivary acidic proline-rich 
phosphoprotein ½, Statherin and Submaxillary gland 
androgen-regulated protein 3B (Table S1). 
The total numbers of proteins identified in each 
group were 40, 21, 28 and 41 for CA, SDS, CA+SDS 
and SDS+CA, respectively. Among them, 15, 14, 14 
and 9 are proteins typically found in the AEP (Table 
1). Additionally, the proteins found exclusively in one 
of the groups was 8, 0, 5 e 4 for the groups CA, SDS, 
CA+SDS and SDS+CA, respectively (Table 1; Figure 1). 
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Fifteen proteins were identified in all groups 
(Figure 1), most of them being proteins typically 
described in the AEP, such as Pancreatic alpha-
amylase, Submaxillary gland androgen-regulated 
protein 3B, Immunoglobulin heavy constant alpha 1, 
Immunoglobulin heavy constant alpha 2, two isoforms 
of Alpha-amylase, three isoforms of Cystatin, Lysozyme 
C and Statherin (Table S1). 
Remarkably, Mucin-7 was only identified in the CA 
and CA+SDS groups, while Protein S100-A9 was only 
found in the CA and SDS+CA groups. On the other 
hand, isoforms of Hemoglobin were only detected in the 
SDS and SDS+CA groups. Moreover, a typical enamel 
protein, Enamelin, was identified in the CA+SDS group 
only. Furthermore, 3 types of PRP were not found in 
the SDS group (Table S1).
Discussion
The proteomic analysis of AEP formed in vitro is 
an important tool in pre-clinical studies since it allows 
preliminary evaluation of preventive agents for dental 
caries and dental erosion. In addition, in in vitro 
studies it is possible to recover the enamel specimens 
over which the AEP is formed to be submitted to 
distinct tests, which is not feasible in vivo. However, 
to date there is only one study where the proteomic 
profile of the AEP formed in vitro was evaluated.25 In 
this sense, our main aim was to develop an in vitro 
protocol of the AEP formation using different solutions 
previously described in the literature to collect AEP 
proteins for shotgun proteomic analysis. 
The main reason for such scarcity of studies is 
the small amount of proteins that can be recovered 
from the in vitro formed AEP, whereas that in in vivo 
condition the AEP is formed under continuous salivary 
flow, which is not present in vitro. In order to overcome 
this, in this study we resupplied the saliva in which 
the specimens were immersed every 30 min during 
the two-hour period of AEP formation. This procedure 
was successful for an in vitro study, since it allowed 
recovery of approximately 30 µg of proteins that is 
enough for proper proteomic analysis. In contrast, pilot 
studies performed for the definition of this protocol 
with the absence of saliva exchange demonstrated the 
failure in the recovery proteins of the AEP (data not 
shown). Despite the fact that saliva was resupplied 
every 30 to increase the total amount of recovered 
proteins, it is possible that the solution used to collect 
the AEP proteins may also influence the amount of 
recovered proteins. 
To date, most of the studies available in the 
literature employ 3% citric acid for collected of the 
acquired pellicle.9-11,14-18,23-25 However, in these studies, 
the proteins collected from 8-10 volunteers are pooled 
in order to obtain enough amount of proteins to be 
analyzed by mass spectrometry, i.e., it is not possible 
to perform individual analysis.  More recently, the 
pellicle proteins formed on ceramic specimens in 
situ were eluted by incubation in TRIS-HCl buffer 
containing SDS, followed by ultrasonication in RIPA-
buffer. This procedure allowed analysis of individual 
samples with high inter-individual and inter-day 
consistency.19 However, it cannot be done in vivo, due 
to the necessity of sonication and to the toxicity of 
the detergents employed.  SDS has been employed 
Figure 1- Venn Diagram with the numbers of the exclusive proteins from each group and the proteins common to two or more group
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Accession 
number




P68032 Actin_ alpha cardiac muscle 1 (d, m, n, q, u, w) 65.6055 X x
P68133 Actin_ alpha skeletal muscle (b, d, m, n, q, u, w)  65.6055 X x
P62736 Actin_ aortic smooth muscle (b, d, m, n, q, u) 65.6055 X x
P60709 Actin_ cytoplasmic 1 (b, m, n, q, u, w) 65.6055 X x
P63261 Actin_ cytoplasmic 2 (a, d, g, j, n, q, u, w) 65.6055 X x
P63267 Actin_ gamma-enteric smooth muscle (b, m, n, q, u, w) 65.6055 X x
P04745 Alpha-amylase 1 (a, g, o, u) 452.4455 X x x x
P19961 Alpha-amylase 2B (a, g, o, u) 579.3912 X x x x
G5E9X6 Basic salivary proline-rich protein 1   (b, l, o, u) 155.8623 X x x
P02812 Basic salivary proline-rich protein 2 (b, l, o, u) 155.8623 X x x
Q562R1 Beta-actin-like protein 2 (b, m, n, u, w) 78.1257 X x
Q96RL1 BRCA1-A complex subunit RAP80 (d, m, p, u) 47.3122 X
P38398 Breast cancer type 1 susceptibility protein (b, e, m, n, p, u) 85.8217 X
Q8N4G4 CA6 protein (a,m,t,u) 76.7328 x x x
P23280 Carbonic anhydrase 6 (a, g, o, u) 301.6657 X x x x
Q9BXL7 Caspase recruitment domain-containing protein 11(c, e, m, n, s, w) 60.8839 X
P08603 Complement factor H (b, m, o, u) 38.0628 x
Q03591 Complement factor H-related protein 1 (a, m, o, w) 38.0628 x
P01036 Cystatin-S (a, b, g, o, u) 2640.733 X x x x
P09228 Cystatin-SA (a, b, g, o, u) 451.4857 x x x x
P01037 Cystatin-SN (a, b, g, o, u) 2646.624 x x x x
Q9UGM3 Deleted in malignant brain tumors 1 protein (f, m, n, o, v, w) 86.0094 x x x x
O75928 E3 SUMO-protein ligase PIAS2 (e, m, p, u) 24.2121 x
Q9NRM1 Enamelin (b, d, m, o, w) 15.9628 x
P68871 Hemoglobin subunit beta (b, c, m, n, o, u, w) 293.9594 x x
P02042 Hemoglobin subunit delta (b, c, m, n, o, u, w) 293.9594 x x
P02100 Hemoglobin subunit epsilon (b, c, m, n, u) 293.9594 x x
P69891 Hemoglobin subunit gamma-1(b, c, h, n, o, u, w) 293.9594 x x
P69892 Hemoglobin subunit gamma-2 (b, c, m, n, u) 293.9594 x x
P01876 Immunoglobulin heavy constant alpha 1 (b, e, i, j, o, u) 866.7542 x x x x
P01877 Immunoglobulin heavy constant alpha 2 (b, e, i, j, o, u) 806.5165 x x x x
P01591 Immunoglobulin J chain (a, b, m, o, w) 946.0537 x
Q8WYH8 Inhibitor of growth protein 5 (b, m, p, u) 95.4649 x
Q9H1B7 Interferon regulatory factor 2-binding protein-like (b, m, p, u) 9.3029 x
P31025 Lipocalin-1 (a, b, m, o, w) 623.5907 x x x x
P61626 Lysozyme C (a, b, g, i, j, o, u, w) 268.2844 x x x x
Q8TAX7 Mucin-7 (b, i, k, o, u) 417.1399 x x
C9JTN7 Nucleolysin TIA-1 isoform p40 (b,m,n,x) 92.8821 x
P04746 Pancreatic alpha-amylase (a, g, o, u) 1996.417 x x x x
Q6S8J3 POTE ankyrin domain family member E (b, m, o, u) 65.6055 x x
A5A3E0 POTE ankyrin domain family member F (b, m, o, u) 65.6055 x x
P0CG38 POTE ankyrin domain family member I (b, m, o, u) 69.466 x
P0CG39 POTE ankyrin domain family member J (b, m, o, u) 69.466 x
A0A0A0MT31 Proline-rich protein 4 (b, l, p, u) 420.9096 x x x
P06702 Protein S100-A9 (a, b, g, i, j, n, o, q, s, u, w) 711.9667 x x
Q9BYX7 Putative beta-actin-like protein 3 (a, m, n, q, u, w) 65.6055 x x
Q5VSP4 Putative lipocalin 1-like protein 1 (b, m, o, x) 204.5444 x x x x
P02810 Salivary acidic proline-rich phosphoprotein 1/2 (b, d, h, l, o, u, v) 420.9096 x x x
Q8NBW4 Sodium-coupled neutral amino acid transporter 9 (f, m, r, u, w) 255.0823 x
Q86WA9 Sodium-independent sulfate anion transporter (c, m, s, u) 262.1345 x
P02808 Statherin (b, e, i, l, o, u) 54090.52 x x x x
P02814 Submaxillary gland androgen-regulated protein 3B (a, g, o, u, w) 3959.276 x x x x
P17987 T-complex protein 1 subunit alpha (e, m, n, w) 59.5312 x
A0A087WZY1 Uncharacterized protein (m, t, x) 420.9096 x x x
P25311 Zinc-alpha-2-glycoprotein (a, b, g, o, u, w) 496.7979 x
Classification of proteins according to: General Function: a) metabolism; b) biological process; c) transport; d) structure and structural 
organization; e) information pathways; f) miscellanea; Function in AP: g) metabolism; h) tissue regeneration; i) antimicrobial; j) immune 
response; k) lubrication; l) biomineralization; m) unknown biological function; Origin: n) cytoplasm origin; o) extracellular origin; p) nucleus 
origin; q) cytoskeleton origin; r) intracellular origin; s) membrane origin; t) unknown protein origin; Interaction: u) protein/protein interaction; 
v) calcium/phosphate binding; w) other molecular interaction; x) unknown molecular interaction. The groups are: 3% citric acid (CA), 0.5% 
sodium lauryl sulfate (SLS), 3% citric acid plus 0.5% sodium lauryl sulfate (CA+SLS) and 0.5% Sodium lauryl sulfate plus 3% citric acid 
(SLS+C).
Table S1- Classification of proteins from the acquired pellicle collected in vitro represented in each group
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Group Accession number Protein Name Score
 CA P68032 Actin_ alpha cardiac muscle 1 65.6055
P68133 Actin_ alpha skeletal muscle 65.6055
P62736 Actin_ aortic smooth muscle 65.6055
P60709 Actin_ cytoplasmic 1 65.6055
P63261 Actin_ cytoplasmic 2 65.6055
P63267 Actin_ gamma-enteric smooth muscle 65.6055
P04745 Alpha-amylase 1 452.4455
P19961 Alpha-amylase 2B 579.3912
G5E9X6 Basic salivary proline-rich protein 1 155.8623
P02812 Basic salivary proline-rich protein 2 155.8623
Q562R1 Beta-actin-like protein 2 78.1257
Q96RL1* BRCA1-A complex subunit RAP80 47.3122
P38398* Breast cancer type 1 susceptibility protein 85.8217
P23280 Carbonic anhydrase 6 144.9005




Q9UGM3 Deleted in malignant brain tumors 1 protein 86.0094
P01876 Immunoglobulin heavy constant alpha 1 866.7542
P01877 Immunoglobulin heavy constant alpha 2 806.5165
P31025 Lipocalin-1 623.5907
P61626 Lysozyme C 268.2844
Q8TAX7 Mucin-7 417.1399
C9JTN7* Nucleolysin TIA-1 isoform p40 92.8821
P04746 Pancreatic alpha-amylase 1996.417
Q6S8J3 POTE ankyrin domain family member E 65.6055
A5A3E0 POTE ankyrin domain family member F 65.6055
A0A0A0MT31 Proline-rich protein 4 420.9096
P06702 Protein S100-A9 711.9667
Q9BYX7 Putative beta-actin-like protein 3 65.6055
Q5VSP4 Putative lipocalin 1-like protein 1 204.5444
P02810 Salivary acidic proline-rich phosphoprotein 1/2 420.9096
Q8NBW4* Sodium-coupled neutral amino acid transporter 9 255.0823
Q86WA9* Sodium-independent sulfate anion transporter 262.1345
P02808 Statherin 54090.52
P02814 Submaxillary gland androgen-regulated protein 3B 3959.276
P17987* T-complex protein 1 subunit alpha 59.5312
A0A087WZY1 Uncharacterized protein 420.9096
P25311* Zinc-alpha-2-glycoprotein 496.7979
SDS P04745 Alpha-amylase 1 274.6967
P19961 Alpha-amylase 2B 274.6967
Q8N4G4 CA6 protein 76.7328




Q9UGM3 Deleted in malignant brain tumors 1 protein 56.2783
P68871 Hemoglobin subunit beta 293.9594
P02042 Hemoglobin subunit delta 293.9594
P02100 Hemoglobin subunit epsilon 293.9594
P69891 Hemoglobin subunit gamma-1 293.9594
P69892 Hemoglobin subunit gamma-2 293.9594
P01876 Immunoglobulin heavy constant alpha 1 290.1472
P01877 Immunoglobulin heavy constant alpha 2 9.2098
P31025 Lipocalin-1 1070.104
Table 1- Proteins identified in the acquired enamel pellicle formed in vitro on enamel specimens and collected using different solutions
Continued on the next page
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P61626 Lysozyme C 731.9259
P04746 Pancreatic alpha-amylase 36.6661
Q5VSP4 Putative lipocalin 1-like protein 1 1070.104
P02808 Statherin 20250.94
P02814 Submaxillary gland androgen-regulated protein 3B 1497.902
CA+SDS P04745 Alpha-amylase 1 181.0646
P19961 Alpha-amylase 2B 166.898
G5E9X6 Basic salivary proline-rich protein 1 552.4909
P02812 Basic salivary proline-rich protein 2 552.4909
Q8N4G4 CA6 protein 67.728
Q8N4G4 CA6 protein 47.9429
P23280 Carbonic anhydrase 6 728.2514
P08603* Complement factor H 38.0628




Q9UGM3 Deleted in malignant brain tumors 1 protein 118.9028
O75928* E3 SUMO-protein ligase PIAS2 24.2121
Q9NRM1* Enamelin 15.9628
P01876 Immunoglobulin heavy constant alpha 1 154.7424
P01877 Immunoglobulin heavy constant alpha 2 79.6826
Q8WYH8* Inhibitor of growth protein 5 95.4649
P31025 Lipocalin-1 1275.895
P61626 Lysozyme C 1199.526
Q8TAX7 Mucin-7 93.5897
P04746 Pancreatic alpha-amylase 166.898
A0A0A0MT31 Proline-rich protein 4 325.6618
Q5VSP4 Putative lipocalin 1-like protein 1 1275.895
P02810 Salivary acidic proline-rich phosphoprotein 1/2 325.6618
P02808 Statherin 32088.14
P02814 Submaxillary gland androgen-regulated protein 3B 1053.619
A0A087WZY1 Uncharacterized protein 325.6618
SDS+CA P68032 Actin_ alpha cardiac muscle 1 145.4612
P68133 Actin_ alpha skeletal muscle 145.4612
P62736 Actin_ aortic smooth muscle 145.4612
P60709 Actin_ cytoplasmic 1 145.4612
P63261 Actin_ cytoplasmic 2 145.4612
P63267 Actin_ gamma-enteric smooth muscle 145.4612
P04745 Alpha-amylase 1 3352.857
P19961 Alpha-amylase 2B 3008.341
G5E9X6 Basic salivary proline-rich protein 1 174.755
P02812 Basic salivary proline-rich protein 2 174.755
Q562R1 Beta-actin-like protein 2 72.3325
Q8N4G4 CA6 protein 48.5939




Q9UGM3 Deleted in malignant brain tumors 1 protein 233.5314
P68871 Hemoglobin subunit beta 761.2395
P02042 Hemoglobin subunit delta 761.2395
P02100 Hemoglobin subunit epsilon 761.2395
P69891 Hemoglobin subunit gamma-1 761.2395
P69892 Hemoglobin subunit gamma-2 761.2395
P01876 Immunoglobulin heavy constant alpha 1 621.9611
P01877 Immunoglobulin heavy constant alpha 2 182.5975
Continued on the next page
Continued from previous page
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to collection AEP proteins in vivo in order to perform 
immunoblotting analysis.20 Since SDS is biocompatible 
and can be used to collected AEP proteins in vivo, in 
the present study we evaluated both 3% citric acid and 
0.5% SDS, alone or in combination, in order to develop 
a method of collection of AEP proteins that results 
in large amount of proteins and can be employed in 
different protocols (in vitro, in situ and in vivo). 
The obtained results indicate that the amount of 
proteins (ranging between 26 and 33 µg) recovered 
when these solutions were used was satisfactory, 
especially considering an in vitro study. Moreover, 
among the 55 proteins identified in all groups, 15 are 
common to all of them, most of which are classical 
players of the AEP. It could be expected that the 
combinations CA + SDS or SDS + CA could increase 
the total number of identified proteins, in comparison 
to CA or SDS only, since the acid and the detergent 
could be expected to remove different proteins of the 
AEP. However, this was not the case, since the total 
number of identified proteins were 40, 21, 28 and 
41 for CA, SDS, CA + SDS and SDS + CA groups, 
respectively. It is also important to consider the quality 
of the identified proteins. Mucin included among the 
pellicle precursors25 and associated with lubrication3 
and protection against erosive challenges26 was only 
identified in the CA and CA + SDS groups. This means 
that the use of SDS first might not remove this protein. 
Moreover, Enamelin, a typical enamel protein, was 
identified only in the CA + SDS group, indicating that 
this combination might remove a layer of enamel.
Thus, the results obtained indicate that the new 
technique develop by resupply of saliva for the AEP 
formation in the present study was essential for a 
higher number of the proteins identified by proteomics 
analysis. In addition, 3% citric acid is, among the 
tested solutions, the best one to remove AEP proteins 
for shotgun proteomic analysis. The amounts and 
quality of proteins recovered when 3% citric acid was 
used is satisfactory, especially considering the in vitro 
protocol of this study. Moreover, the amount of proteins 
recovered when CA was used (around 30 µg) might 
be enough to allow proteomic analysis of biological 
triplicates, since not assessing the biological variability 
is currently the major shortcoming of the proteomic 
studies of the AEP. It would be desirable to compare 
the proteomic profile of AEPs formed in vitro, in situ 
and in vivo, so that the results of in vitro and in situ 
studies can be extrapolated to the clinical condition.  
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